Skip to main content

Result of the Questionnaire

  • Conference paper
  • 1047 Accesses

Abstract

In this chapter we report the results of a questionnaire circulated among the faculty of the Baveno VI portal hypertension consensus workshop in January 2015. When possible, the results were compared to those of a similar questionnaire that was circulated 5 years before as a preparation to the previous edition of the consensus workshop. The answers were used to unravel opinions among the experts in portal hypertension, which were further discussed during the workshop.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. European Association for the Study of the Liver (2010) EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol 53:397–417

    Article  Google Scholar 

  2. Vilstrup H, Amodio P, Bajaj J, Cordoba J, Ferenci P, Mullen KD, Weissenborn P, Wong F (2014) Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology 60:715–735

    Article  PubMed  Google Scholar 

  3. de Franchis R; on behalf of the Baveno III Chairpersons and Panelists (2000) Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol 33:846–852

    Google Scholar 

  4. Elkrief L, Lebrec D (2014) Beta-blockers for all … or not. In: de Franchis R, Dell’Era A (eds) Variceal hemorrhage. Springer, New York, pp 63–73

    Chapter  Google Scholar 

  5. Sersté T, Melot C, Francoz C, Durand F, Rautou PE, Valla D et al (2010) Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites. Hepatology 52:1017–1022

    Article  PubMed  Google Scholar 

  6. Sersté T, Francoz C, Durand F, Rautou PE, Melot C, Valla C et al (2011) Beta-blockers cause paracentesis-induced circulatory dysfunction in patients with cirrhosis and refractory ascites: a cross-over study. J Hepatol 55:794–799

    Article  PubMed  Google Scholar 

  7. Bang UC, Benfield T, Hyldstrup L et al (2013) Beta-blockers do not impact negatively on survival rates in cirrhotic patients with diuretic resistant ascites. A Danish nationwide population based study. Hepatology 58:263A–264A

    Google Scholar 

  8. Ferrarese A, Germani G, Rodriguez-Castro KI, Nadal E, Zanetto A, Bortoluzzi I et al (2014) Bleeding-unrelated mortality is not increased in patients with cirrhosis and ascites on treatment with β-blockers: a meta-analysis. Dig Liver Dis 46, e31

    Article  Google Scholar 

  9. Kimer N, Feineis M, Moeller S, Bendtsen F et al (2015) Beta-blockers in cirrhosis and refractory ascites: a retrospective cohort study and review of the literature. Scand J Gastroenterol 50:129–137

    Article  CAS  PubMed  Google Scholar 

  10. Krag A, Bendtsen F, Moeller S (2011) Does cardiac dysfunction explain deleterious effects of beta-blockers incirrhosis and refractory ascites? Hepatology 53:370–371

    Article  PubMed  Google Scholar 

  11. Krag A, Wiest R, Albillos A, Gluud LL (2012) The window hypothesis: haemodynamic and non-haemodynamic effects of beta-blockers improve survival of patients with cirrhosis during a window of the disease. Gut 61:967–969

    Article  CAS  PubMed  Google Scholar 

  12. Krag A, Gluud LL (2014) When to stop non-selective beta-blockers: the window hypothesis in clinical practice. J Gastrointestin Liver Dis 23:458 (letter)

    Article  PubMed  Google Scholar 

  13. Krag A, Madsen BS (2015) To block, or not to block in advanced cirrhosis and ascites: that is the question. Gut 64:1015–1017

    Google Scholar 

  14. GE PS, Runyon BA (2014) When should the beta-blocker window in cirrhosis close? Gastroenterology 146:1597–1599

    Article  PubMed  Google Scholar 

  15. La Mura V, Tosetti G, Primignani M, Salerno F (2015) Use of non-selective beta blockers in cirrhosis: the evidence we need before closing (or not) the window. World J Gastroenterol 21:2265–2268

    Article  PubMed  PubMed Central  Google Scholar 

  16. Mandorfer M, Bota S, Schwabl P et al (2014) Nonselective beta blockers increase risk for hepatorenal syndrome and death in patients with cirrhosis and spontaneous bacterial peritonitis. Gastroenterology 146:1680–1690

    Article  CAS  PubMed  Google Scholar 

  17. Gluud LL, Krag A (2012) Banding ligation versus beta-blockers for primary prevention in oesophageal varices in adults. Cochrane Database Syst Rev (8):CD004544

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Carlo Merkel .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this paper

Cite this paper

Merkel, C., Krag, A. (2016). Result of the Questionnaire. In: de Franchis, R. (eds) Portal Hypertension VI. Springer, Cham. https://doi.org/10.1007/978-3-319-23018-4_20

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-23018-4_20

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-23017-7

  • Online ISBN: 978-3-319-23018-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics